

Volunteers Needed for Weber County STEM events

Myriad Genetics announced financial results for its fourth quarter and year ended Dec. 31, 2021.

SINTX Technologies announced new results on the development of manufacturing technologies to produce fabrics impregnated with SINTX silicon…

Renalytix announced its intention to appoint Timothy Scannell to its board of directors as an independent non-executive director.

PolarityTE announced results from a multi-center randomized controlled trial evaluating treatment of Venous Leg Ulcers (VLU) with its…

In this year’s legislative session, two bills could be problematic for life sciences companies in Utah. HB60 prohibits…

Life Sciences Day on Capitol Hill was held on February 16 filling the Capitol rotunda with 24 companies…

First-of-its kind metal-alloy angioplasty scoring sheath effective in treatment of critical arterial stenosis

Researchers at ARUP Laboratories made significant contributions to the advancement of laboratory medicine in 2021 as coauthors of…

PolarityTE, Inc. announced the U.S. Patent and Trademark Office (USPTO) recently issued a Notice of Allowance for U.S.…

ARUP’s commitment to creating a satisfying work environment for employees has earned it a spot on Forbes’ list…

Appointment further expands leadership team to support aggressive commercialization of the company’s PressON™ fixation, Tranquil™ interbody, and pending…

FDA-Cleared REMI Platform to Begin Initial Commercialization to Hospitals for Use in Emergency Departments and Intensive Care Units…

Originally published by IONIQ Sciences Dear IONIQ Sciences Shareholders and Friends, Greetings from IONIQ Sciences where we continue to…

BioPharm Laboratories, another journal article from the Journal of Biological Chemistry cites the use of BioPharm’s High Purity…

SALT LAKE CITY, Feb. 3, 2022 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company”), a molecular diagnostics company with…

Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development…

New Nelson Labs Mark offers transparency and confidence in product testing

Salt Lake City, UT, February 2, 2022 – IONIQ Sciences, Inc. (“IONIQ” or the “Company”) announced today that…

Fluidx Medical Reports Initial Research on First-of-its-Kind Embolic Agent with Intermediate Radiopacity

Biomerics inaugurated its second plant in Costa Rica.

Fluidx Medical’s Novel Embolic Device Demonstrates Repeated Success in Treating Complex Tumors

Foldax Appoints Scott Huennekens to Board of Directors

PolarityTE, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved its investigational new drug (IND)…

Co-Diagnostics, Inc. announced that CoSara Diagnostics Pvt Ltd has received clearance by the Central Drugs Standard Control Organization (“CDSCO”)…

New Peripheral Vascular Microcatheters Save Procedure Time and Advance Treatment Capabilities

Positive Study Results Published for KidneyIntelXTM in Monitoring Patient Response to New Drug Therapy

Premier Neurology Facility in Colorado Joins the CenExel Centers of Excellence

CenExel Clinical Research, Inc. announced the acquisition of California Neuroscience Research.

Nexus Spine announced key appointments to its leadership team that includes David Ivanko as Vice President of Quality…

Seventh KidneyIntelX implementation partnership for Renalytix focused on underserved populations with high disease burden

PARK CITY, Utah and HERZLIYA, Israel, Jan. 6, 2022 /PRNewswire/ — BlueWind Medical™, Ltd., developer of the innovative RENOVA™…

National program establishes early care management, technology innovation and large health system engagement as a strategic priority for…

Series A Financing Funds Multiple Programs to Phase 1 and IND stage

Definitive merger agreements provide the Company with all existing and future assets, future product iterations, and intellectual property…

Publication in Journal of the American College of Cardiology (JACC): Cardiovascular Interventions Found TRIA Aortic Heart Valve Provided…

PolarityTE has submitted its complete response to the U.S. FDA clinical hold correspondence regarding its Investigational New Drug…

Myriad Genetics Promotes Nicole Lambert to Chief Operating Officer

Teiko.bio Launches with $11.6 Million Series A Financing to Advance High-Dimension Immune Profiling for Clinical Trials and Diagnostics…

Rosivo closes seed-round paving the path for commercialization of patented cartilage implant technology